Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Vibrant’s New Title Empowers Emerging Developers With the Foundations of Efficient, Real-World Programming

Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...
IEEE

Dynamic Pricing Strategy for Data Product Through Deep Reinforcement Learning

Abstract: With the rapid development of the data trading market, traditional fixed pricing strategies can no longer effectively reflect the real value of data products, thereby restricting the ...
IEEE

SPADNet: Structure Prior-Aware Dynamic Network for Face Super-Resolution

Abstract: The recent emergence of deep learning neural networks has propelled advancements in the field of face super-resolution. While these deep learning-based methods have shown significant ...
Seeking Alpha

Structure: Maintaining Strong Buy As Aleniglipron Succeeds In Obesity Study Program

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Seeking Alpha

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...